SavedAdd your journal

Journals / The anatolian journal of family medicine (Online) / 2019 / Cilt: 2 - Sayı: 3

Evaluation of Vaccine-Preventable Diseases, HIV and HCV Antibody Levels in Residents

Ahmet AYRANCI
Kamile MARAKOĞLU
Duygu FINDIK
Muhammet KIZMAZ
Hatice DAĞI
Pages
108–118
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Vaccine declaration of theresidents and their serology results compared by Kapaa test and the findings showed that low or negligiblecompliance for hepatitis B (ĸ=0.153 p=0.022) and found low intermediate compliance for hepatitis A (ĸ=0.217p 0.05).Conclusion: As a result, increasing compliance with the residents for safeguard measures, assessment of serological status before beginning the work, and then, the vaccine for the seronegative disease and in-housetraining to increase vaccine awareness are necessary.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In our study, we aimed to evaluate the vaccine-preventable diseases and viral serology status ofresidents to prevent all the potential risks.Methods: Referring to this study list dated 11/01/2014, 203 residents working in Selcuk University Faculty ofMedicine were included in this study from the Department of Internal Medicine, Department of Surgical Medical Sciences and Department of Basic Medical Sciences.
📊
Key Findings & Data:A questionnaire that consisted of 27 questions wasadministered using the face to face interview method.
💡
Conclusion & Impact:Vaccine declaration of theresidents and their serology results compared by Kapaa test and the findings showed that low or negligiblecompliance for hepatitis B (ĸ=0.153 p=0.022) and found low intermediate compliance for hepatitis A (ĸ=0.217p 0.05).Conclusion: As a result, increasing compliance with the residents for safeguard measures, assessment of serological status before beginning the work, and then, the vaccine for the seronegative disease and in-housetraining to increase vaccine awareness are necessary.
🔬Design:Survey & Empirical Study
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: In our study, we aimed to evaluate the vaccine-preventable diseases and viral serology status ofresidents to prevent all the potential risks.Methods: Referring to this study list dated 11/01/2014, 203 residents working in Selcuk University Faculty ofMedicine were included in this study from the Department of Internal Medicine, Department of Surgical Medical Sciences and Department of Basic Medical Sciences. A questionnaire that consisted of 27 questions wasadministered using the face to face interview method. Anti-HAV IgG anti-HBs, HBsAg, anti-HCV and anti-HCVlevels were measured by COBAS/E- 601 device with ELISA method. Measles IgG, rubella IgG, mumps IgG weremeasured by VIDAS device with ELFA method at Selcuk University Faculty of Medicine Department of Microbiology laboratory. SPSS for Windows 21.0 statistical software was used in the analysis of all the data.Results: In this study, all of the residents’ HBsAg (n=203, 100%), anti-HCV and anti-HIV levels were normal and9 (4.4%) of the residents were no immune to mumps. Of the residents; 3 (1.5%) were no immune to rubella.Of the residents; 21 (10.3%) were no immune to measles. Of the residents; 52 (25.6%) were no immune tohepatitis A. Anti-HBs antibody levels were measured range to 0.0-9.9 mIU/mL as 13 (6.4%) of the residents and≥10 mIU/mL as 190 (93.6%). Of the residents; 13 (6.4%) were no immune to varicella. Vaccine declaration of theresidents and their serology results compared by Kapaa test and the findings showed that low or negligiblecompliance for hepatitis B (ĸ=0.153 p=0.022) and found low intermediate compliance for hepatitis A (ĸ=0.217p 0.05).Conclusion: As a result, increasing compliance with the residents for safeguard measures, assessment of serological status before beginning the work, and then, the vaccine for the seronegative disease and in-housetraining to increase vaccine awareness are necessary.

🔖

Cite This Article

AYRANCI, A., MARAKOĞLU, K., FINDIK, D., KIZMAZ, M., DAĞI, H. (2019). Evaluation of Vaccine-Preventable Diseases, HIV and HCV Antibody Levels in Residents. The anatolian journal of family medicine (Online), Cilt: 2 - Sayı: 3, 108–118. https://ajindex.com/articles/365047

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Maltezou HC, Poland GA. Vaccination policies for healthcare workers inEurope. Vaccine 2014;32(38):4876–80
  2. EKMUD Erişkin bağışıklama rehberi. Available at: http://ekmud.org.tr/emek/rehberler/1-ekmud-rehberleri. Accessed Nov 06, 2019
  3. T.C. Sağlık Bakanlığı Sağlık Personeline Uygulanacak Aşı Takvimi 2010 T.C. Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü. Genişletilmiş Bağışıklama Programı Genelgesi. Available at: https://dosyasb.saglik.gov.tr/Eklenti/1117,gbpgenelge2008pdf.pdf. Accessed Nov 30, 2006
  4. Tekin A, Deveci Ö. Seroprevalences of HBV, HCV and HIV among healthcare workers in a state hospital. J Clin Exp Invest 2010;1(2):99–103
  5. T.C. Sağlık Bakanlığı Kurumu. Hıv/aıds veri Tabloları Available at: http://www.hatam.hacettepe.edu.tr/veriler_Haziran_2013. pdf. Accessed Nov 06, 2019
  6. Dokuzoğuz B. Sağlık çalışanlarında güncel aşı önerileri ANKEM Derg 2014;28:199–206
  7. Landis JR, Koch GG. Themeasurement of observer agreement for categorical data. Biometrics 1977;33(1):159–74
  8. Köse Ş, Sarıca A, Çevik FÇ, Cüce M. Yüksek risk grubunda olan sağlık çalışanlarında viral hepatit A, B, C seroprevalansı. Viral Hepatit Dergisi 2003;8(3):152–4
  9. Öksüz Ş, Yıldırım M, Özaydın Ç, Şahin İ, Ara¬bacı H, Gemici G. Bir devlet hastanesi sağlık çalışanlarında HBV ve HCV seroprevalansının araştırılması. Ankem Derg 2009;23(1):30–3
  10. Çakaloğlu Y, Ökten A. Hepatit B (Ulusal Uz¬laşma Toplantı Metinleri). İstanbul: Medikal Yayıncılık; 2005. p.99–102
  11. Tosun S. Hepatit B aşılaması ve ülkemizde hepatit aşılama sonuçları. Tabak F, Tosun S, editors. Viral Hepatit 2013. İstanbul: Viral Hepatitle Savaşım Derneği Yayını; 2013. p.413–37
  12. Cılız N, Gazi H, Ecemiş T, Şenol Ş, Akcalı S, Kurutepe S. Seroprevalance of Measles, Rubella, Mumps, Varicella, Diphtheria, TetanusandHepatitis B in Healthcare Workers. Klimik Dergisi 2013;26(1):26–30
  13. Alp E, Cevahir F, Gökahmetoglu S, Demiraslan H, Doganay M. Pre Vaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save? J Infect Public Health 2012;5(2):127–32
  14. Kutlu R, Çivi S, Aslan R. Measles, rubella, mumps and hepatitis B seroprevalence among the female medical students. TAF Preventive Medical Bulletin 2011;10(5):549–56 15. Öncü S, Ozturk B, Aydemir M, Oncu S, Sakarya S. Sağlık çalışanları ve öğrencilerinde Anti-HAV IgG prevalansı. Viral Hepatit Dergisi 2004;3:162–5
  15. Korkmaz P, Cağlan FC, Aykın N, Alpay Y, Gulduren